Richard Ramko

Background

About Richard Ramko

Life Sciences Assurance Leader - EY West Region; providing insight and guidance to biotech, med device, and pharma companies. Clients have included large publicly-held multi-national corporations as well as venture-backed emerging companies and start-ups. Frequent speaker on industry and financial reporting trends and contributor of articles to numerous Ernst & Young thought leadership publications on technical accounting issues such as business combinations, revenue recognition, collaborative arrangements, and pre-launch inventory. Additionally, published M&A Accounting Changes on the Horizon in The Journal of Biolaw and Business. Actively involved with the Association of Bioscience Financial Officers (“ABFO”) Board of Directors and have been the EY lead for the annual ABFO conference planning committee since 2006. Specialties: Assisting client executives and boards with business, operational, governance, and strategic matters. Significant SEC-related experience particularly with respect to S-1 (Initial Public Offering) and secondary offerings, complex accounting issues, business combinations, and helping clients work through SEC comment letters and related responses. Professional Designations: Currently holding active CPA certificates in California, Washington, Massachusetts, Florida, and Tennessee and a member of the American Institute of Certified Public Accountants.